After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
We are very excited to launch our new website! Please take a few moments to click around and explore...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...